RIGEL PHARMACEUTICALS INC

Nasdaq:RIGL

Pharmaceutical Preparations·SOUTH SAN FRANCISCO, CA

Rigel is a blue supergiant star in the equatorial constellation of Orion. It has the Bayer designation β Orionis, which is Latinized to Beta Orionis and abbreviated Beta Ori or β Ori.

Financials

20 shown

Type	Period	Ended	Filed
10-K	FY 2025	12/31/25	3/3/26	→
10-Q	Q3 2025	9/30/25	11/4/25	→
10-Q	Q2 2025	6/30/25	8/5/25	→
10-Q	Q1 2025	3/31/25	5/6/25	→
10-K	FY 2024	12/31/24	3/4/25	→
10-Q	Q3 2024	9/30/24	11/7/24	→
↓

Earnings Releases (8-K)

37 shown

Filed	Period
3/3/26	Q1 FY2026	→
1/12/26	Q4 FY2026	→
11/4/25	Q4 FY2025	→
8/5/25	Q3 FY2025	→
5/6/25	Q2 FY2025	→
3/4/25	Q1 FY2025	→
↓

News (8-K)

43 shown

Filed	Type	Description
2/3/26	Exec Change	Departure or Appointment of Directors or Certain Officers	→
12/10/25	Other	Other Events	→
5/23/25	Exec Change	Departure or Appointment of Directors or Certain Officers	→
3/27/25	Other	Other Events	→
3/10/25	Exec Change	Departure or Appointment of Directors or Certain Officers	→
12/9/24	Other	Other Events	→
↓

Prospectuses & Registrations

40 shown

Filed	Form	Description
8/6/25	S-8	S-8	→
4/10/25	ARS	ARS	→
8/6/24	S-8	S-8	→
8/2/24	S-3	S-3	→
4/10/24	ARS	ARS	→
8/1/23	S-8	S-8	→
↓

Filing History(1000 filings)

TypeDateAccessionPeriodSize

8-K

Mar 3, 2026

0001034842-26-0000168-K

Mar 3, 2026

292.3 KB

10-K

Mar 3, 2026

0001034842-26-00001510-K

Dec 31, 2025

11.1 MB

Feb 24, 2026

0000905148-26-001015FORM 4

Feb 20, 2026

8.1 KB

144

Feb 20, 2026

0001959173-26-001277

—

4.2 KB

Feb 19, 2026

0000905148-26-000956FORM 4

Feb 17, 2026

4.6 KB

Feb 19, 2026

0000905148-26-000955FORM 4

Feb 17, 2026

4.6 KB

Feb 19, 2026

0000905148-26-000953FORM 4

Feb 17, 2026

4.7 KB

Feb 19, 2026

0000905148-26-000954FORM 4

Feb 17, 2026

4.7 KB

Feb 19, 2026

0000905148-26-000952FORM 4

Feb 17, 2026

4.6 KB

Feb 12, 2026

0000905148-26-000678FORM 4

Feb 10, 2026

4.3 KB

Feb 12, 2026

0000905148-26-000676FORM 4

Feb 10, 2026

4.3 KB

Feb 12, 2026

0000905148-26-000679FORM 4

Feb 10, 2026

4.3 KB

Feb 12, 2026

0000905148-26-000675FORM 4

Feb 10, 2026

4.3 KB

Feb 12, 2026

0000905148-26-000677FORM 4

Feb 10, 2026

4.3 KB

SCHEDULE 13G

Feb 9, 2026

0000093751-26-000084

—

7.7 KB

Feb 4, 2026

0000905148-26-000498

Feb 2, 2026

4.4 KB

Feb 4, 2026

0000905148-26-000497

Feb 2, 2026

4.3 KB

Feb 4, 2026

0000905148-26-000496

Feb 2, 2026

4.3 KB

Feb 4, 2026

0000905148-26-000495

Jan 26, 2026

14.3 KB

Feb 3, 2026

0000905148-26-000482

Feb 1, 2026

5.4 KB

Feb 3, 2026

0000905148-26-000475

Feb 1, 2026

10.2 KB

8-K

Feb 3, 2026

0001034842-26-0000078-K

Feb 1, 2026

137.6 KB

8-K

Jan 12, 2026

0001034842-26-0000058-K

Jan 12, 2026

206.6 KB

Dec 29, 2025

0000905148-25-004492

Dec 22, 2025

14.6 KB

8-K

Dec 10, 2025

0001104659-25-119976FORM 8-K

Dec 7, 2025

216.7 KB

25 filings shown

RIGEL PHARMACEUTICALS INC

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(1000 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
4/10/25	DEFA14A	DEFA14A	→
4/10/25	DEF 14A	DEF 14A	→
4/10/24	DEFA14A	FORM DEFA14A	→
4/10/24	DEF 14A	DEF 14A	→
3/29/24	PRE 14A	PRE 14A	→
5/15/23	DEFR14A	DEFR 14A	→
↓

Filed	Form	Description
2/24/26	4	4	→
2/19/26	4	4	→
2/19/26	4	4	→
2/19/26	4	4	→
2/19/26	4	4	→
2/19/26	4	4	→
↓

Filed	Form	Description
2/20/26	144	144	→
2/9/26	SCHEDULE 13G	SCHEDULE 13G	→
11/14/25	SCHEDULE 13G/A	SCHEDULE 13G/A	→
10/7/25	SCHEDULE 13G/A	SCHEDULE 13G/A	→
8/14/25	SCHEDULE 13G/A	SCHEDULE 13G/A	→
8/5/25	SCHEDULE 13G/A	SCHEDULE 13G/A	→
↓